| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |